{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:45:05Z","timestamp":1781621105658,"version":"3.54.5"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejim.2017.11.013","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T05:01:08Z","timestamp":1512190868000},"page":"e31-e32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Immunohistochemistry as confirmatory test for current Helicobacter pylori infection in patients treated with proton pump inhibitors"],"prefix":"10.1016","volume":"50","author":[{"given":"Anca","family":"Negovan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Iancu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Mocan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Banescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2017.11.013_bb0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2017.05.017","article-title":"The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with long-term low-dose aspirin and proton pump inhibitor therapy","volume":"44","author":"Negovan","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"18","key":"10.1016\/j.ejim.2017.11.013_bb0010","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/CIRCULATIONAHA.108.191087","volume":"118","author":"Bhatt","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.11.013_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence consensus report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"issue":"Suppl. 4","key":"10.1016\/j.ejim.2017.11.013_bb0020","doi-asserted-by":"crossref","first-page":"S373","DOI":"10.1016\/S1590-8658(11)60593-8","article-title":"Gastritis: the histology report","volume":"43","author":"Rugge","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"10","key":"10.1016\/j.ejim.2017.11.013_bb0025","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1136\/gutjnl-2014-307595","article-title":"The stomach in health and disease","volume":"64","author":"Hunt","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2017.11.013_bb0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2036.1998.00310.x","article-title":"Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease","volume":"12","author":"Stolte","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2017.11.013_bb0035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/apt.13324","article-title":"Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology","volume":"42","author":"Lundell","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2017.11.013_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2017.117","article-title":"Proton-pump inhibitors: understanding the complications and risks","author":"Malfertheiner","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517304788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517304788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T14:06:49Z","timestamp":1535206009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517304788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":8,"alternative-id":["S0953620517304788"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.11.013","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemistry as confirmatory test for current Helicobacter pylori infection in patients treated with proton pump inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}